Literature DB >> 21254840

Pathobiology of junctional adhesion molecules.

Gianfranco Bazzoni1.   

Abstract

Junctional adhesion molecules are transmembrane proteins that belong to the immunoglobulin superfamily. In addition to their localization in close proximity to the tight junctions in endothelial and epithelial cells, junctional adhesion molecules are also expressed in circulating cells that do not form junctions, such as leukocytes and platelets. As a consequence, these proteins are associated not only with the permeability-regulating barrier function of the tight junctions, but also with other biologic processes, such as inflammatory reactions, responses to vascular injury, and tumor angiogenesis. Furthermore, because of their transmembrane topology, junctional adhesion molecules are poised both for receiving inputs from the cell interior (their expression, localization, and function being regulated in response to inflammatory cytokines and growth factors) and for translating extracellular adhesive events into functional responses. This review focuses on the different roles of junctional adhesion molecules in normal and pathologic conditions, with emphasis on inflammatory reactions and vascular responses to injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254840     DOI: 10.1089/ars.2010.3867

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  16 in total

Review 1.  Claudins: control of barrier function and regulation in response to oxidant stress.

Authors:  Christian E Overgaard; Brandy L Daugherty; Leslie A Mitchell; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2011-05-09       Impact factor: 8.401

2.  Cell-cell junctions: structure and regulation in physiology and pathology.

Authors:  Mir S Adil; S Priya Narayanan; Payaningal R Somanath
Journal:  Tissue Barriers       Date:  2020-12-10

3.  Relocalization of junctional adhesion molecule A during inflammatory stimulation of brain endothelial cells.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

4.  Novel flow cytometric analysis of the blood-brain barrier.

Authors:  Dionna W Williams; Lydia Tesfa; Joan W Berman
Journal:  Cytometry A       Date:  2015-04-30       Impact factor: 4.355

Review 5.  Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.

Authors:  Ka Wai Mok; Dolores D Mruk; C Yan Cheng
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 6.  JAM-related proteins in mucosal homeostasis and inflammation.

Authors:  Anny-Claude Luissint; Asma Nusrat; Charles A Parkos
Journal:  Semin Immunopathol       Date:  2014-03-26       Impact factor: 9.623

7.  Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.

Authors:  Candice E Van Skike; Jordan B Jahrling; Angela B Olson; Naomi L Sayre; Stacy A Hussong; Zoltan Ungvari; James D Lechleiter; Veronica Galvan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

8.  Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.

Authors:  Anny-Claude Luissint; Cédric Artus; Fabienne Glacial; Kayathiri Ganeshamoorthy; Pierre-Olivier Couraud
Journal:  Fluids Barriers CNS       Date:  2012-11-09

9.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Expression of regulatory platelet microRNAs in patients with sickle cell disease.

Authors:  Shilpa Jain; Maria G Kapetanaki; Nalini Raghavachari; Kimberly Woodhouse; Guoying Yu; Suchitra Barge; Claudia Coronnello; Panayiotis V Benos; Gregory J Kato; Naftali Kaminski; Mark T Gladwin
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.